Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dentifrice With Innovative Remineralizing Technology: a Randomized Clinical Study (REFIX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04730908
Recruitment Status : Recruiting
First Posted : January 29, 2021
Last Update Posted : January 29, 2021
Sponsor:
Information provided by (Responsible Party):
Fabio Correia Sampaio, Federal University of Paraíba

Brief Summary:
Objective: The aim of this study is to evaluate in vivo dentifrices containing different active ingredients in fluoride (F) retention in saliva and dental biofilm. Material and methods: The dentifrices used in the study were: G1- Daily Regenerator Dentalclean Neutral (RDCN); G2- Sensodyne Repair & Protect (SRP); G3- Daily Regenerator Dentalclean Acid (RDCA), G4- Colgate Total Daily Repairc (CTDR). A double-blind, randomized crossover clinical study was conducted with eighteen residents of a city without a water fluoridation program. Biofilm and saliva samples were collected 1h and 12h after the last brushing for biofilm and, 1 to 60 minutes and 12 hours for saliva. The concentrations of F in saliva and biofilm were analyzed by specific electrode using the hexamethyldisiloxane facilitated diffusion technique (HMDS). Data were analyzed by repeated measures ANOVA followed by the Bonferroni test (p <0.05). Area under the curve (AUC) was calculated for saliva data. Result: No significant difference was observed between the groups regarding the retention of F in saliva. However, the largest area under the curve values in saliva were found for groups G3 and G4. The highest median values of F-biofilm were found in G3 for 1h and 12h collection times. Conclusion: The toothpaste containing Refix (RDCA) technology presented the most promising results for fluoride retention in oral exposure biomarkers.

Condition or disease Intervention/treatment Phase
Fluoride Biomarkers in the Oral Mouth After Brushing Teeth With the Experimental Dentifrice Bioavailability of Fluoride in the Oral Mouth Other: DENTIFRICE Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: Crossover study testing 4 dental gel for brushing teeth. the brushing period of use :7 days, 3 times daily with wahs-out periods of one week.
Masking: Triple (Participant, Care Provider, Investigator)
Masking Description: the products are coded with different color in the label.
Primary Purpose: Prevention
Official Title: Dentifrice With Innovative Remineralizing Technology: a Randomized Clinical Study
Actual Study Start Date : February 3, 2020
Estimated Primary Completion Date : April 12, 2021
Estimated Study Completion Date : September 12, 2021

Arm Intervention/treatment
Placebo Comparator: G0 - placebo
Dental gel without fluoride in the composition
Other: DENTIFRICE
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Name: TOOTHPASTE

Sham Comparator: G1: Daily Regenerator Dentalclean Neutro (RDCN)
1450 ppm F- of sodium fluoride and tetrasodium pyrophosphate (Refix technology). NEUTRAL pH
Other: DENTIFRICE
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Name: TOOTHPASTE

Active Comparator: G2: Sensodyne Repair & Protect (SRP)
1426 ppm of sodium fluoride and calcium sodium phosphosilicate 5% (NOVAMIN technology).
Other: DENTIFRICE
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Name: TOOTHPASTE

Experimental: G3: Daily Regenerator Dentalclean Acid (RDCA)
1450 ppm F- of sodium fluoride and tetrasodium pyrophosphate (Refix technology). ACIDIC FORMULA
Other: DENTIFRICE
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Name: TOOTHPASTE

Active Comparator: G4: Colgate Total Daily Repair (CTDR)
1450 ppm F- of as sodium fluoride, 0.30% triclosan, arginine, tetrasodium pyrophosphate.
Other: DENTIFRICE
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Name: TOOTHPASTE




Primary Outcome Measures :
  1. FLUORIDE IN SALIVA [ Time Frame: 12 hours ]
    Concentration of fluoride in saliva after brushing teeth

  2. FLUORIDE IN DENTAL PLAQUE [ Time Frame: 12 hours ]
    Concentration of fluoride in dental biofilm after brushing teeth



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • The eligibility criteria were people over 18 years old, without systemic commitment and living in the city of João Pessoa-Paraíba, without water fluoridation (< 0.1 μg/mL F).

Exclusion Criteria:

  • Individuals were excluded if they used drugs that interfere with biofilm formation and salivary flow or fluoride products (> 5000 ppm) in the last 4 weeks, used orthodontic appliances, or had cavity lesions, periodontal disease, and/or tooth sensitivity.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04730908


Locations
Layout table for location information
Brazil
Federal University of Paraíba Recruiting
João Pessoa, Paraíba, Brazil
Contact: Fábio C Sampaio, Doctor    +55 83 32167795    fcsampa@gmail.com   
Sponsors and Collaborators
Federal University of Paraíba
Layout table for additonal information
Responsible Party: Fabio Correia Sampaio, Professor, Federal University of Paraíba
ClinicalTrials.gov Identifier: NCT04730908    
Other Study ID Numbers: REFIX-UFPB
First Posted: January 29, 2021    Key Record Dates
Last Update Posted: January 29, 2021
Last Verified: January 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No